The new technique is now the 'prime candidate' for potential clinical trials, raising hopes that for the first time, a ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment prolongs survival.

About five years ago, Lowe began experiencing concerning symptoms, such as blood in his bowel movements. He knew he had a ...

A study involving researchers from Karolinska Institutet indicates that prostate cancer can be diagnosed at an early stage ...

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Padeliporfin VTP (brand name Tookad) has previously been approved by the European Union, Israel, and Mexico as a treatment for low-risk prostate cancer, following demonstration of significant clinical ...

Loyola High volleyball coach Michael Boehle learns how to deal with prostate cancer that fortunately was diagnosed early and ...

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.